Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled trial of doxycycline to prevent cetuximab-induced acneiform rash
2010-022044-20Phase 3Terminated
- Sponsor
- María de los Ángeles Álvarez López
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acneiform disorders comparing Doxycycline prophylaxis with Placebo prophylaxis (2 arms). Primary endpoints: Quality of life and Intensity of acneiform eruption. Started Oct 2010; status: terminated.
02
Drugs
doxycycline
03
Conditions
acneiform disorders
Beyond the preview
Go deeper on 2010-022044-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022044-20.